GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ARCA biopharma Inc (FRA:HQ10) » Definitions » Market Cap

ARCA biopharma (FRA:HQ10) Market Cap : €31.53 Mil (As of Mar. 13, 2025)


View and export this data going back to 1997. Start your Free Trial

What is ARCA biopharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ARCA biopharma's share price for the quarter that ended in Jun. 2024 was €39.6. ARCA biopharma's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 1.21 Mil. Therefore, ARCA biopharma's market cap for the quarter that ended in Jun. 2024 was €47.88 Mil.

ARCA biopharma's quarterly market cap increased from Dec. 2023 (€22.76 Mil) to Mar. 2024 (€23.05 Mil) and increased from Mar. 2024 (€23.05 Mil) to Jun. 2024 (€47.88 Mil).

ARCA biopharma's annual market cap increased from Dec. 2021 (€27.53 Mil) to Dec. 2022 (€32.20 Mil) but then declined from Dec. 2022 (€32.20 Mil) to Dec. 2023 (€22.76 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ARCA biopharma's Enterprise Value for Today is €1.39 Mil.


ARCA biopharma Market Cap Historical Data

The historical data trend for ARCA biopharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARCA biopharma Market Cap Chart

ARCA biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.14 30.57 27.53 32.20 22.76

ARCA biopharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.30 26.88 22.76 23.05 47.88

Competitive Comparison of ARCA biopharma's Market Cap

For the Biotechnology subindustry, ARCA biopharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARCA biopharma's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ARCA biopharma's Market Cap distribution charts can be found below:

* The bar in red indicates where ARCA biopharma's Market Cap falls into.



ARCA biopharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ARCA biopharma's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€18.84*1.208
=€22.76

ARCA biopharma's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€39.6*1.209
=€47.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ARCA biopharma  (FRA:HQ10) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


ARCA biopharma Market Cap Related Terms

Thank you for viewing the detailed overview of ARCA biopharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


ARCA biopharma Business Description

Traded in Other Exchanges
N/A
Address
10170 Church Ranch Way, Suite 100, Westminster, CO, USA, 80021
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

ARCA biopharma Headlines

No Headlines